FDA's Social Media Guidance Skirts Questions Of Liability
The U.S. Food and Drug Administration's long-awaited draft guidance on social media sets limits for how drugmakers can respond to questions about off-label uses, but provides no guidelines for responding to...To view the full article, register now.
Already a subscriber? Click here to view full article